Identification |
Name: | Androstan-3-one,17-hydroxy-, (5a,17b)- |
Synonyms: | 5a-Androstan-3-one, 17b-hydroxy- (8CI);(+)-Androstan-17b-ol-3-one;17b-Hydroxy-3-androstanone;17b-Hydroxy-5a-androstan-3-one;17b-Hydroxy-5a-androstane-3-one;4,5a-Dihydrotestosterone;4-Dihydrotestosterone;5a,17b-Hydroxyandrostan-3-one;5a-Androstan-17b-ol-3-one;5a-Androstanolone;5a-Dihydrotestosterone;Anaboleen;Anabolex;Andractim;Androlone;Androstan-17b-ol-3-one;Androstanolone;Cristerona MB;DHT;Dihydrotestosterone;LG 152;NSC 10972;Neodrol;Stanaprol;Testosterone, dihydro-; |
CAS: | 521-18-6 |
EINECS: | 208-307-3 |
Molecular Formula: | C19H30O2 |
Molecular Weight: | 290.44 |
InChI: | InChI=1/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1 |
Molecular Structure: |
|
Properties |
Density: | 1.085g/cm3 |
Stability: | Stable at normal temperatures and pressures. |
Refractive index: | 1.536 |
Alpha: | 27 o |
Solubility: | Insoluble |
Appearance: | US DEA Schedule III |
Packinggroup: | II |
Storage Temperature: | Keep tightly closed. |
Usage: | Anabolic steroid. Controlled substance |
Safety Data |
|
|